Fred Aslan

Company: Artiva Biotherapeutics, Inc

Job title: President & Chief Executive Officer

Seminars:

Industry Leader’s Fireside Chat: Discussing Present Advancements & Challenges in the Natural Killer Space to Envision the Future of NK Therapy 8:30 am

Discussing key advancements in the NK space to highlight the therapeutic potential of NK biology Sharing the latest findings in NK therapy and what this means for this field What are the biggest hurdles in this space that still need to be overcome?Read more

day: Day 1 AM

Panel Discussion: Exploring Current & Future Opportunities in Entering the Autoimmune Field as an NK Developer 9:00 am

What makes NK applications to the autoimmune space so exciting? Discussing recent advancements that showcase the promise of NK based therapy in autoimmune disease  Evaluating the main hurdles in expanding NKs to the autoimmune space Why is there more funding in autoimmunity than oncology?Read more

day: Pre-Conference Focus Day

Why NK Cells Versus Other Modalities in Autoimmune Disease? 10:00 am

Comparing and contrasting NK cell therapy as a modality to treat autoimmune disease as opposed to other cell therapies Evaluating NK cell therapy for autoimmune diseases versus oncologyRead more

day: Pre-Conference Focus Day